Related Experiment Video
Updated: Jul 19, 2025

An Automated T-maze Based Apparatus and Protocol for Analyzing Delay- and Effort-based Decision Making in Free Moving Rodents
Published on: August 2, 2018
Apathy and Motivation: Biological Basis and Drug Treatment
Harry Costello1, Masud Husain2, Jonathan P Roiser1
1Institute of Cognitive Neuroscience, University College London, London, United Kingdom;
Abstract:
Apathy is a disabling syndrome associated with poor functional outcomes that is common across a broad range of neurological and psychiatric conditions. Currently, there are no established therapies specifically for the condition, and safe and effective treatments are urgently needed. Advances in the understanding of motivation and goal-directed behavior in humans and animals have shed light on the cognitive and neurobiological mechanisms contributing to apathy, providing an important foundation for the development of new treatments. Here, we review the cognitive components, neural circuitry, and pharmacology of apathy and motivation, highlighting converging evidence of shared transdiagnostic mechanisms. Though no pharmacological treatments have yet been licensed, we summarize trials of existing and novel compounds to date, identifying several promising candidates for clinical use and avenues of future drug development.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Introduction to Biological Bases of Psychology
The nervous system, the cornerstone of...
Primary Motives: Sleep, Sex, and Pain Avoidance
Sleep is a fundamental physiological drive that fosters a state of restfulness crucial for several bodily functions. It facilitates body restoration, the process by which the body repairs, rejuvenates, and maintains itself during sleep, including memory...
Alzheimer's Disease: Treatment
Drugs Affecting Neurotransmitter Release or Uptake
Drug Therapy
Antianxiety Medications

